“…In two previous VHL deletion studies, a reduced risk for renal cell carcinoma has been noted when the actin regulator gene HSPC300 was codeleted together with the VHL gene [Maranchie et al, 2004;Cascó n et al, 2007]. While a number of studies have characterized partial and complete germline deletions of the VHL gene by quantitative Southern blot, multiplex ligation-dependent probe amplification (MLPA), and/or quantitative real-time polymerase chain analyses (qPCR) [Stolle et al, 1998;Hes et al, 2000;Cybulski et al, 2002;Gallou et al, 2004;Maranchie et al, 2004;Hoebeeck et al, 2005;Casarin et al, 2006;Hattori et al, 2006;Cascó n et al, 2007;Hes et al, 2007;Huang et al, 2007;Ong et al, 2007] and while some of the breakpoints have been narrowed down more precisely, the exact breakpoint sequence has only been determined for one case, which was shown to result from Alu-Alu recombination [Casarin et al, 2006]. Alu-Alu recombination-mediated deletions have been described for various inherited disorders such as familial hypercholesterolemia and a-thalassemia [for reviews see Deininger and Batzer, 1999;Batzer and Deininger, 2002].…”